Literature DB >> 9215813

Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis.

M F Chen1, L R Mo, R C Lin, J Y Kuo, K K Chang, C Liao, F J Lu.   

Abstract

The aim of this study is to investigate the relationship between the resting level of superoxide anion (O2.) and liver cirrhosis (LC). The resting levels of superoxide anion in the whole blood of healthy controls and patients with compensated or decompensated LC were measured, by an ultra-sensitive chemiluminescence (CL) analyzer and lucigenin amplification. The assay system can be performed in the absence of leukocyte isolation and stimulant administration. The results showed that the blood CL levels of compensated cirrhotic patients (381.0 +/- 201.5 counts/10 s, mean +/- SD, n = 24) were similar to that of healthy controls (467.9 +/- 299.5 counts/10 s, n = 24). However, the blood CL levels of decompensated cirrhotic patients (2083.5 +/- 1462.4 counts/10 s, n = 24) were significantly greater than that of healthy controls and patients with compensated LC (both p < .001, Student's t-test). The correlation analysis revealed that the blood CL levels in cirrhotic patients were significantly correlated with serum concentrations of albumin (r = -0.65, p < .001) and total bilirubin (r = +0.42, p < .005). However, there was no significant correlation between the blood CL levels and serum levels of transaminases (GOT and GPT). These results suggest that blood levels of superoxide of decompensated cirrhotic patients were greater than those of healthy controls or compensated cirrhotic patients. Moreover, the increase of blood levels of superoxide in decompensated cirrhotic patients is related to the impairment of liver function but not to the inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215813     DOI: 10.1016/s0891-5849(97)00057-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

Review 1.  Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy.

Authors:  Cristina R Bosoi; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

2.  Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease.

Authors:  P Ljubuncic; Z Tanne; A Bomzon
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

3.  Clastogenic factors as potential biomarkers of increased superoxide production.

Authors:  Ingrid Emerit
Journal:  Biomark Insights       Date:  2007-12-11

Review 4.  Clinical science workshop: targeting the gut-liver-brain axis.

Authors:  Vishal C Patel; Helen White; Sidsel Støy; Jasmohan S Bajaj; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2015-10-08       Impact factor: 3.584

5.  Cytogenetic methods for detection of oxidative stress and evaluation of antioxidant therapy in hepatitis C infection.

Authors:  Ingrid Emerit
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

6.  Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan.

Authors:  M M Wu; H Y Chiou; T W Wang; Y M Hsueh; I H Wang; C J Chen; T C Lee
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

7.  Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.

Authors:  Wei Chen; De-Jun Liu; Yan-Miao Huo; Zhi-Yong Wu; Yong-Wei Sun
Journal:  Int J Biol Sci       Date:  2014-03-15       Impact factor: 6.580

8.  Intragastrically Applicated CCl4-Thiopental Sodium Enhanced Lipid Peroxidation and Liver Fibrosis (Cirrhosis) in Rat: Malonedialdehyde as a Parameter of Lipid Peroxidation Correlated with Hydroxyproline as a Parameter of Collagen Synthesis (Deposition).

Authors:  Ki-Young Kim; Syung-Eun Cho; Byung-Soo Yu
Journal:  Toxicol Res       Date:  2009-06-01

9.  Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis.

Authors:  Seren Ozenirler; Banu Sancak; Ugur Coskun
Journal:  Biomark Insights       Date:  2008-03-12

10.  Probiotics (VSL#3) prevent endothelial dysfunction in rats with portal hypertension: role of the angiotensin system.

Authors:  Sherzad K Rashid; Noureddine Idris-Khodja; Noureddine Idris Khodja; Cyril Auger; Mahmoud Alhosin; Nelly Boehm; Monique Oswald-Mammosser; Valérie B Schini-Kerth
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.